drugset / Trial / NCT01433900
Switching From Preserved to Preserved-free Treatments for Glaucoma.
RandomizedParallel-groupOpen-labelTreatment
Summary
A 1-year prospective, randomized, investigator-masked trial comparing the confocal and clinical effects of treatment with unpreserved prostaglandins (tafluprost) versus preserved prostaglandins (latanoprost) in newly-diagnosed glaucoma patients.
Timeline
- Start
- 2012-05
- Primary completion
- 2013-05
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latanoprost | Small molecule | 0.005 % | Topical |
| Comparator | Tafluprost | Other / unclassified | 0.0015 % | Topical |